Indeed, PPARγ, a ligand-activated transcription factor, implicated in adipogenesis and glucose metabolism [55] regulates adiponectin and other genes associated with PAH, and has been suggested as a possible and therein useful therapeutic agent [56]. Here, ADIPOQ is linked to pulmonary arterial hypertension.